Abstract:The listing of authors was incorrect in the published version. The correct author names and affiliations appear as above. The authors would like to include the following acknowledgments: We wish to thank Prof. K. Fukunaga (Tohoku University) for generously providing the antibodies (Nitrotyrosine, HtrA2, Fas, Fas ligand and TNFa). We also thank Dr. S. Moriguchi and N. Shioda (Tohoku University) for helpful comments and constructive discussion on the manuscript. Thisworkwas supported in part byNational Natural Science Foundations of China (30672564 to Y. Lou; 30973521 to F. Han), The Science Research Foundation of Chinese Ministry of Health (WKJ2009-2-029 to F. Han), The Key Foundation of Zhejiang Educational Committee (Z200803527 to F. Han) and by the Key Foundation of Modernization of Chinese Traditional Medicine of Zhejiang Province (2006C13075 to Y. Lou). The authors would like to apologize for any inconvenience caused.

Corrigendum: Neuroprotection by upregulation of the major histocompatibility complex class I (MHC I) in SOD1G93A mice

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

Corrigendum to "Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington's disease in the mouse model" 413-429]

Corrigendum: Oligodendrocyte, Astrocyte and Microglia Crosstalk in Myelin Development, Damage, and Repair

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Corrigendum: Vi4-miR-185-5p-Igfbp3 Network Protects the Brain From Neonatal Hypoxic Ischemic Injury via Promoting Neuron Survival and Suppressing the Cell Apoptosis

Erratum: Tejeda-Bayron et al. Activation of Glutamate Transporter-1 (GLT-1) Confers Sex-Dependent Neuroprotection in Brain Ischemia. Brain Sci. 2021, 11, 76

Corrigendum: Mechanisms of mitophagy and oxidative stress in cerebral ischemia–reperfusion, vascular dementia, and Alzheimer's disease

Corrigendum: Neuroprotective Effects of Celastrol on Transient Global Cerebral Ischemia Rats via Regulating HMGB1/NF-κB Signaling Pathway

Corrigendum: Sestrin2 Protects Against Hypoxic Nerve Injury by Regulating Mitophagy Through SESN2/AMPK Pathway.

Corrigendum: Müller Cell Regulated Microglial Activation and Migration in Rats With N-Methyl-N-Nitrosourea-Induced Retinal Degeneration

Corrigendum: Neuroprotectin D1 protects against postoperative delirium-like behavior in aged mice.

Corrigendum to "Dexmedetomidine Ameliorates Hippocampus Injury and Cognitive Dysfunction Induced by Hepatic Ischemia/Reperfusion by Activating SIRT3-Mediated Mitophagy and Inhibiting Activation of the NLRP3 Inflammasome in Young Rats"

Corrigendum to "Spermidine Prevents Heart Injury in Neonatal Rats Exposed to Intrauterine Hypoxia by Inhibiting Oxidative Stress and Mitochondrial Fragmentation"

Corrigendum: Combination effect of three main constituents from Sarcandra glabra inhibits oxidative stress in the mice following acute lung injury: a role of MAPK-NF-κB pathway

Corrigendum To: NGF Protects Neuroblastoma Cells Against Β‐amyloid Induced Apoptosis Via the Nrf2/HO‐1 Pathway

Corrigendum: Treatment of Surgical Brain Injury by Immune Tolerance Induced by Peripheral Intravenous Injection of Biotargeting Nanoparticles Loaded with Brain Antigens

Corrigendum: The cerebellum and fear extinction: evidence from rodent and human studies

Corrigendum to 'CRISPR/Cas9 system and its applications in nervous system diseases' [Genes & Diseases 11 (2024) 675-686]